Purple Xin Pharmaceutical Industry additional premium 80% raise capital 1 billion processing ginseng

Purple Xin Pharmaceutical plan to drop 1 billion invested in the ginseng industrialization project really attracted the capital, Purple Xin Pharmaceutical (002118, closing price 32.08 Yuan) announced today (December 31) The issuance of the results show that the final issue of prices than the release of 77%, to the latest close calculation,　　The additional participants have 60% of the surplus.　　Additional price floating nearly 80% purple Xin pharmaceutical industry announced today, the company issued a total of 49.8753 million shares, successfully raised the net amount of funds for 986 million yuan. From the entire distribution process, the purple Xin Pharmaceutical Investment project prospects for the funds are optimistic. The company and the main underwriter received a total of 9 purchase quotes, Taiping Asset Management Co., Ltd. reported a 24.40 yuan/share of the highest price, more than 11.29 yuan/share of the issuance of the floor is more than one times more than a century cosmetic Care Products Co., Ltd. also reported a high price of 23.31 yuan per share.　　In the end, 9 of the declared objects were out of 3, and the price of this issue was determined to be 20.05 yuan/share, which was about 77% of the release of the earlier plan. The assigned object also has its own story. Taiping Asset Management Co., Ltd. for the Taiping Insurance Group under the asset management agencies; century Cosmetic Care Products Co., Ltd. is a group of Zhejiang na AI, affiliated enterprises, in the past one or two years participated in a number of well-known listed companies to issue additional; In addition, Societe Generale Global Fund Management Co., Ltd.,　　Domestic private equity fund Tianjin Silicon Valley Paradise, the Partnership Enterprise, Changbai Mountain Equity Investment Management Co., Ltd. and a natural Yang Fu army.　　In terms of the price, 6 of the allocated objects in the Changbai Mountain Equity Investment Management Co., Ltd. the largest use of funds, more than 260 million yuan, and 4 other legal entities to use funds in 160 million yuan ~1.8 billion, the natural person Yang Fu army was hit 77.7 million yuan heavily.　　The prospect of the business of ginseng Purple Xin Pharmaceutical industry to raise funds will be directed to the series of ginseng products, the project is expected to be completed, the company will have 800 tons of deep processing capacity of ginseng. Changjiang Securities analyst Shangpeng pointed out that since the end of 2009, Jilin Province, the intensive introduction of ginseng industry revitalization of the relevant policies, the Ministry of Health has tentatively agreed to Jilin Ginseng and medicine homologous pilot, industrial development has policy background support　　, in the last month, the company signed a strategic cooperation agreement with the Tonghua government of Jilin Province and Changchun branch of the Chinese Academy of Sciences to cooperate fully in the ginseng industry, which is expected to bring more policy concessions and tilt to the development of ginseng business. Since the beginning of the July release of additional plans, the purple-Xin pharmaceutical industry in the two market day by day, the share price has quadrupled.